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Abstract
Background: People with intermittent claudication are at increased risk of death from heart attack and stroke
compared to matched controls. Surgery for intermittent claudication is for symptom management and does not
reduce the risk of cardiovascular morbidity and mortality. Increasing physical activity can reduce claudication
symptoms and may improve cardiovascular health. This paper presents the pilot study protocol for a randomised
controlled trial to test whether a brief psychological intervention leads to increased physical activity, improvement
in quality of life, and a reduction in the demand for surgery, for patients with intermittent claudication.
Methods/Design: We aim to recruit 60 patients newly diagnosed with intermittent claudication, who will be
randomised into two groups. The control group will receive usual care, and the treatment group will receive usual
care and a brief 2-session psychological intervention to modify illness and walking beliefs and develop a walking
action plan. The primary outcome will be walking, measured by pedometer. Secondary outcomes will include
quality of life and uptake of surgery for symptom management. Participants will be followed up after (a) 4 months,
(b) 1 year and (c) 2 years.
Discussion: This study will assess the acceptability and efficacy of a brief psychological intervention to increase
walking in patients with intermittent claudication, both in terms of the initiation, and maintenance of behaviour
change. This is a pilot study, and the results will inform the design of a larger multi-centre trial.
Trial Registration: Current Controlled Trials ISRCTN28051878
Background
Patients with Peripheral Arterial Disease (PAD) have
been described as ‘a high risk, but neglected, disease
population’ [1]. The disease is common in older adults,
has serious health implications, but is not as intensively
treated as other cardiovascular diseases [2]. PAD is
caused by atherosclerosis in the leg arteries, which leads
to a reduction in blood supply to the lower limbs. The
most common symptom of PAD is intermittent claudi-
cation (IC), leg pain when walking. The prevalence of
PAD increases with age, Fowkes et al [3] found that
4.5% of 55 to 74 years olds had IC in the Edinburgh
Artery Study, with prevalence increasing to over 20% of
over 75 year olds [4].
Atherosclerotic build-up ont h ew a l l so fa r t e r i e si sn o t
confined to one part of the arterial system, therefore a
diagnosis of IC is an indicator of atherosclerosis in other
parts of the body. Indeed, patients diagnosed with IC
are at increased risk of cardiovascular co-morbidity and
mortality. Caro et al [5] analysed a large database of
patients with PAD and found that 33% of patients with
PAD died, mainly from cardiovascular events, within
5 years of diagnosis of IC. A diagnosis of IC can therefore
be seen as an important early warning sign of future car-
diovascular problems, and should trigger measures to
reduce the risk of death and vascular co-morbidity [6].
Many of the risk factors for atherosclerosis are beha-
vioural, and include smoking, lack of physical activity,
high cholesterol levels, high blood pressure, diabetes and
obesity. Treatment for patients diagnosed with IC
includes risk factor modification and surgery. Walking
benefits patients with PAD as it reduces blood pressure,
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development of a collateral blood supply [7]. In a
Cochrane review of exercise for intermittent claudica-
tion, Leng et al [8] found significant improvements in
walking distance following exercise therapy, the most
effective exercise regimens involving walking to near-
maximal pain, three times a week. Leng called for
further research to determine the degree of supervision
required in an exercise programme, and how long
changes in exercise could be expected to last following
participation in an exercise programme.
At present in the UK, supervised exercise programmes
for patients with IC are relatively uncommon, therefore
exercise for claudication is usually promoted by advice
alone. Stewart & Lamont [9] indicated a number of rea-
s o n sw h ya d v i c ea l o n em a yn o tb ea p p r o p r i a t ef o r
patients with IC, including patients’ loss of confidence/
self-efficacy in their ability to walk, their embarrassment
at having to stop and rest, and their concerns that pain
may be an indication that walking is harmful to them.
The aim of this RCT is to test a brief psychological inter-
vention designed to improve walking in patients with IC.
In our recent qualitative study of factors associated
with walking in patients with IC, we found that two belief
systems influenced walking - (1) beliefs about the illness,
and (2) beliefs about walking [10]. We found that patients
with claudication tended to have a poor understanding of
the causes of their illness, the health consequences of
their illness, or the benefits of walking either to their gen-
eral health or to reduce claudication symptoms.
While some previous studies using brief psychological
interventions to increase physical activity in populations
at high risk of developing cardiovascular disease have had
disappointing results e.g. [11-13], the present study differs
because (i) the intervention is designed to address the
barriers to walking particular to patients with IC, whereas
other studies have included heterogeneous groups of
patients facing a wide range of unknown barriers to phy-
sical activity; (ii) the patients included in this study have
sought treatment for their disease and are therefore pre-
sumably more motivated to adhere to treatment than
patients being offered unsolicited interventions to
increase physical activity; (iii) this study will objectively
directly measure behaviour change, in the form of mean
daily steps as measured by pedometer, rather than relying
on self-report measures of physical activity, or objective
measures of fitness as a proximal measure of behaviour
change; (iv) this study will measure all outcomes at three
time points, 4 months, 1 year and 2 years from baseline,
thereby distinguishing between initiation and mainte-
nance of behaviour change - previous studies have not
tended to measure all outcomes at all time points and
therefore cannot distinguish between the initiation and
maintenance of behaviour change.
Framework
Our intervention was designed using the MRC Frame-
work for the development and evaluation of complex
interventions to improve healthcare [14]. We identified
existing evidence for the benefit of walking therapy to
patients with claudication, and have conducted a quali-
tative study to identify key psychological constructs
associated with walking in claudicants. Our theoretical
framework is based around Leventhal et al’s [15] Com-
mon-sense model of self-regulation of health and illness
(CSM), a dynamic model which considers both the role
of illness representations and treatment representations
in an individual’s coping actions. The CSM suggests that
patients’ illness representations are based on beliefs
about the causes of the illness, how long the illness will
last, whether the illness is curable, and the perceived
consequences of the illness. Treatment representations
can be characterised using the same framework as ill-
ness representations - behavioural actions have an iden-
tity (e.g. the name of the action), time lines (e.g. the
length of time the behaviour will take to achieve the
goal, and when and for how long the behaviour has to
be carried out), consequences (e.g. outcome expectations
about the consequences of the behaviour; judgement
about the risk of performing the action), causes (e.g. the
mechanism by which the coping action will work) and
control (e.g. whether the action will cure or control
symptoms or the underlying disease; the individual’s
beliefs about their ability to carry out the behaviour).
The model proposes that the content of these represen-
tations determines the cognitive and behavioural actions
which the individual will take to cope with the illness.
We have identified evidence-based behaviour-change
techniques successfully used in other interventions to
modify the psychological constructs highlighted in the
CSM [16].
This trial is a pilot to test whether a brief psychologi-
cal intervention to modify these constructs can lead to
an increase in walking in IC patients. In the pilot study
we will test recruitment and retention rates, preliminary
efficacy of the intervention at both short and long-term
follow-up, acceptability of the intervention, and accept-
ability of pedometers as a way of measuring walking
behaviour in this patient group. The results from this
pilot trial will provide an effect size to inform the power
and sample size calculations for a larger, multi-centre
trial.
Trial objectives
To examine whether:
￿ a brief psychological intervention can improve
walking and quality of life for patients with intermit-
tent claudication;
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demand for surgery for symptom management;
￿ improvement in walking is mediated by changes in
illness and walking beliefs;
￿ participation in the intervention improves surgical
outcomes e.g. walking behaviour and quality of life,
for participants who have surgery.
Methods/Design
Recruitment
Participants will be recruited from the Intermittent
Claudication Outpatient Clinic in NHS Forth Valley.
This is a nurse-led clinic which diagnoses people with
IC. People are referred from GPs based in Forth Valley.
At diagnosis, the Vascular Assessment Nurse will invite
consecutive patients to take part in the trial. In order to
check representativeness of the participants who agree
to take part in the trial, the Vascular Assessment Nurse
will ask for verbal consent to retain all patients’ age,
gender and Ankle Brachial Pressure Index information,
whether they agree to participate in the trial or not.
Currently 200 patients are diagnosed each year in the
Forth Valley Intermittent Claudication clinic. A sample
size calculation carried out using GPower3 [17], indi-
cates that to carry out a (2) group by (2) time mixed
ANOVA to detect a small effect size (0.2) with an alpha
of 0.05, and a power of 80%, the trial would require 26
participants in each condition. A small effect size of 0.2
was selected in the sample size calculation based on a
previous study of an exercise program for physical activ-
ity in patients with IC which measured walking out-
comes using pedometers [18]. The sample size
calculation was based on the conservative initial (2) time
point (baseline to 4 month) mixed ANOVA to increase
the likelihood that the study was adequately powered to
identify an initiation of walking behaviour change. A (4)
time point mixed ANOVA sample size calculation
required fewer participants in the study, and therefore
the larger, initial (2) time point, more conservative sam-
ple size calculation was used. The sample size calcula-
tion was based on changes in the primary outcome
measure. As this is a pilot study, a further aim is to
determine the effect sizes achieved in the secondary out-
come measures, to help inform the sample size calcula-
tion for a larger, more definitive study. Based on a
previous study with patients from this population
recruited at outpatient clinic, we estimate that 25% of
people may decline to participate in the study. Likely
attrition rate from the study for this population is
unknown, therefore we have estimated a 10% attrition
rate during the trial. We therefore aim to invite 80
patients to participate in the trial, of whom we expect
60 to agree to participate, and a further 6 to drop-out
during the course of the trial. Based on typical numbers
presenting at the clinic who are diagnosed with claudi-
cation, recruitment is estimated to take place at the rate
of 2 participants/week.
Inclusion Criteria
Patients presenting to the Forth Valley Vascular Outpa-
tient Clinic, newly diagnosed with IC in one or both
legs will be recruited into the study. A diagnosis of
lower limb arterial disease causing intermittent claudica-
tion will be established by a vascular assessment nurse
or consultant surgeon. This will be based on a combina-
tion of investigations including post-exercise ABPI of
below 0.9 [6], and duplex ultrasound, magnetic reso-
nance angiography (MRA) or computerised tomography
angiography to provide an anatomic view of the arteries.
Exclusion Criteria
W ew i l lo n l ye x c l u d ep e o p l ew h oa r eu n a b l et og i v e
informed consent (e.g. due to dementia) or for whom it
may be medically unadvisable to increase their daily
walking, including patients with heart failure, cancer,
patients who cannot walk unaided or patients with a
history of orthopaedic surgery which affects walking.
Patients with an ABPI of less than 0.35 will also be
excluded as they are likely to be offered emergency
surgery.
Design
This is a pilot randomised controlled trial with patients
newly diagnosed with IC randomly allocated to one of two
groups. Allocation to group will be carried out by the
researcher, who will use a computer generated random
number table for allocation (http://www.randomizer.org/).
The computer generated random number table was
created at the start of the study by a research colleague,
who is not involved in participant recruitment or alloca-
tion. The researcher will assign consecutive participant
numbers to patients as their names are sent to her by the
Vascular Assessment Nurse, each participant number will
then correspond to a treatment group as established in the
computer generated random number table. The researcher
will therefore assign participants to groups before she has
made any contact, and before she has received any infor-
mation about them other than their name and phone
number. Participants allocated to the control condition
will receive usual care. Participants allocated to the inter-
vention group will receive usual care and a brief, 2-session
psychological intervention. The Vascular Assessment
Nurse who provides usual care at diagnosis, and who
recruits participants, will be blind to participant allocation
to groups. Other clinical staff in contact with participants
during their care, e.g. Vascular Technologists and Vascular
Surgeons will be blind to participant allocation to groups.
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ure 1.
Setting
This is a single-centre trial based in NHS Forth Valley,
Scotland.
Ethical Approval
Ethical approval has been obtained from Fife and Forth
Valley Research Ethics Committee (REC ref. no. 08/
S0501/6).
Intervention
Participants in the intervention group will receive 9 vis-
its from the researcher in their own home, including 4
visits to complete questionnaires, 2 one hour interven-
tion sessions, and 3 other visits to drop off or pick up
pedometers.
Session 1
The researcher will elicit any maladaptive beliefs the
participant has about their illness, or about walking.
Information will be provided about the consequences of
the illness, and about the behaviour-health link in order
to modify illness and walking beliefs. Motivational inter-
viewing techniques will be used to deliver the interven-
tion, asking open questions, prompting the participant
to make self-motivating statements and evaluations of
their own walking behaviour and aiming to move parti-
cipants to a point where they have expressed motivation
or intention to change their walking behaviour. A copy
of the schedule used to guide the discussion in Session1
is provided in Additional File 1.
Session 2
The researcher will work with the participant to draw
up an individualised walking action plan, based on the
recommendation of walking to near maximal pain three
times a week [8]. Participants will be encouraged to
think about how they can adapt their daily routines to
incorporate a half hour of continuous walking, and will
also be encouraged to think of possible barriers which
may prevent them from following their action plan, and
strategies to cope with these barriers. Sniehotta et al
[19] found that a combination of action planning and
coping planning led to much greater improvement in
physical exercise than action planning alone. Action
plans will then be typed up and laminated, and posted
out to participants. A copy of the template for an action
plan is provided in Additional File 2.
Control
Participants in the control group will receive 8 visits
from the researcher, in their own home, including 4 vis-
its to complete questionnaires and a further 4 visits to
either drop off or pick up the pedometer. This is only 1
less visit from the researcher than participants in the
intervention group. The researcher will engage control
group participants in non-walking related conversation
in an attempt to control for the potentially confounding
effects of social contact.
Usual Care
Participants in the intervention group and control condi-
tion will receive usual care while participating in the
study. All participants will be diagnosed as having inter-
mittent claudication by the Vascular Assessment Nurse,
who provides all patients with an information sheet about
Peripheral Arterial Disease and advises patients to ‘stop
smoking and start walking’. All participants then attend
an outpatient clinic to meet with a Vascular Surgeon,
who will discuss appropriate treatment with the patient.
Appropriate treatment depends on the age and health of
the patient, the size and location of the narrowing of the
artery, and on the patient’s wishes. If the patient chooses
surgical intervention they will then be put on a waiting
list for surgery or angioplasty. Approximately 56% of
patients diagnosed with IC in NHS Forth Valley proceed
to receive angioplasty or surgery, usually within 6 months
of diagnosis. If the patient chooses conservative treat-
ment, they will be invited to attend a further outpatient
clinic in 3 months time, and then discharged if their clau-
dication symptoms remain stable. Patients who receive
angioplasty are followed up by the surgeon for 1 year and
then discharged; patients who receive surgery are
followed up by the surgeon for 5 years.
At the time of 4 month follow-up in the RCT, all
patients will have attended the outpatient clinic to meet
the Vascular Surgeon, and a treatment decision will
have been made. However, patients will be on a waiting
list and will not have received treatment.
Telephone Calls
The researcher will call participants in both groups, 6
and 12 weeks after recruitment into the study. The pur-
pose of the call will be to:
￿ Intervention group - discuss progress against the
action plan with participants in the intervention
group, playing particular attention to barriers to
walking, and encouraging participants to use their
coping plans, and come up with alternative strategies
to overcome barriers. Changes to a participant’s
action plan or coping plan may be agreed with a
participant in the phone call.
￿ Both groups - ask participants if they have heard
from the hospital and what treatment, if any, has
been agreed upon.
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dard questions about general health, satisfaction
with health, quality of life [20], pain rating [21], and
pain free walking distance [22].
Outcome Measures
Measures will be taken for participants in both arms of
t h es t u d y ,a tb a s e l i n e ,4m o n t h s ,1a n d2y e a rf o l l o w -
ups. All questionnaires will be administered by the
researcher.
Primary Outcome - walking
Previous studies of walking in patients with intermittent
claudication have tended to measure maximal walking
distance on the treadmill. While this measure gives an
accurate idea of how far a patient can walk before they
experience claudication pain, and before they have to
stop, it does not give any idea of how much walking the
patient does in their day to day life, and therefore lacks
ecological validity. For this reason, we have decided to
measure day-to-day walking using pedometers. Partici-
pants will be asked to wear a pedometer for one week
at each time point, and their mean daily steps will be
calculated by averaging the six days with the highest
number of steps.
Patients will be shown how to use the pedometer at
each time point, and will be encouraged to telephone
the researcher if they have any problems with the
pedometer.
Other Measures
Self-reported walking ability will be measured with the
question ‘How far can you walk, aided or unaided, under
normal circumstances before the onset of pain?’ to which
there are 6 possible responses - ‘0y a r d s ’, ‘up to 100
yards’, ‘up to 250 yards’, ‘up to half a mile’, ‘up to 1 mile’,
‘more than a mile’. The question is adapted from
Mondillo et al’s [22] Claudication Self-Assessment with
the distances being re-formatted from metres to yards to
reflect the fact that older patients are more likely to be
confident measuring distance in imperial units. In order
to measure frequency of walking to the onset of pain,
participants are asked ‘In general, how frequently do you
walk that distance?’ with 6 possible responses - ‘never’,
‘once or twice a month’, ‘once a week’, ‘2-3 times a
week’, ‘4-5 times a week’,a n d‘everyday’.
A self-report measure of walking will also be com-
pleted, as a comparison for walking as measured by ped-
ometer. The International Physical Activity
Questionnaire (IPAQ) [23] is a self-report measure of
physical activity with 4 items measuring time spent in
vigorous and moderate activity, time spent walking, and
time spent sitting.
Quality of life will be measured using the Intermittent
Claudication Questionnaire [21] a disease specific qual-
ity of life measure.
Illness beliefs will be measured using the Brief Illness
Perception Questionnaire [24], adapted to reflect Periph-
eral Arterial Disease as the illness in question.
There is no standard measure of treatment representa-
tions, however walking personal control (walking confi-
dence) questions will be tailored to people with
intermittent claudication based on methods described in
Francis et al [25]; and treatment consequences (walking)
questions will be tailored to people with intermittent
claudication based on methods described in Renner &
Schwarzer [26].
We will also document all surgery received since the
last visit.
Analysis
Data will be analysed using an intention to treat proto-
col in a repeated measures mixed design (2 groups*2
time points for short-term outcome, and 2 groups*4
time points for long-term outcome). Our aim is to
determine the effect size achieved by this pilot to inform
the sample size calculation for a larger, multi-centre
study. Between-group differences in uptake of surgery
will be measured using a chi-square test.
Evaluation
The effectiveness of the intervention will be determined
through analysis of the outcome variables listed above.
Analysis of the primary outcome variable will determine
whether the brief psychological intervention group have
increased walking in comparison with the control group.
The psychological measures will be analysed to deter-
mine whether improvement in walking is mediated by
changes in illness and walking beliefs.
On completion of the study, participants in the interven-
tion group will be asked additional semi-structured ques-
tions about their experience of the intervention including
what they thought of their action plan, whether they fol-
lowed their action plan, whether the barriers they pre-
dicted prevented them from following their action plan,
whether they used their coping plan, whether they intend
to follow their action plan in the future, and whether they
thought it was worthwhile to take part in the study.
Discussion
A brief psychological intervention which increases walk-
ing in claudicants may (a) reduce the demand for sur-
gery for patients with intermittent claudication; (b)
reduce costs for the NHS; (c) be accessible and accepta-
ble for patients and lead to long term behaviour change;
(d) encourage patient self-management of their chronic
condition; and (e) increase patient quality of life.
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increase walking in claudicants have either relied on the
provision of advice, which does not overcome barriers
to walking for claudicants; or supervised exercise pro-
grammes, which are not commonly available and which
may not be an acceptable means of intervention for
many claudicants for a variety of psychological and
environmental reasons. This is the first time a psycholo-
gical intervention based on the CSM has been carried
out to increase walking in patients with intermittent
claudication. The intervention is patient-centred, can be
tailored to the specific needs of each individual, and has
directly measured behaviour change (walking) as the pri-
mary outcome. A health economic evaluation would be
central to any subsequent large-scale trial.
A clear theoretical framework underpins the interven-
tion, and the content of the intervention is clearly speci-
fied and based on thoroughly tested and evidenced
health psychology techniques. The intervention is cap-
able of being delivered by trained non-specialist health
workers in an NHS setting.
Additional material
Additional file 1: Questions for Session One. Schedule to guide
Session One, using questions based on motivational interviewing
techniques to discuss the participant’s beliefs about their illness, provide
information on the illness, provide information on the benefits of
walking, and discuss the participant’s motivation to change their walking
behaviour.
Additional file 2: Template for Action and Coping Plan. Template for
an action and coping plan to be completed with the participant by the
researcher, in the participant’s own words. The plan can include three
specific actions which the participant will undertake to increase their
walking. Prompts for discussing possible barriers to action are included in
the template. The template is adapted from the Improving Health:
Changing Behaviour - NHS Health Trainer Handbook [27].
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